Pricing Log in Create free account

Pasithea Therapeutics Corp. (KTTA) vs RVL Pharmaceuticals PLC (RVLP)

Pasithea Therapeutics Corp. and RVL Pharmaceuticals PLC are both Biotechnology companies. Pasithea Therapeutics Corp. and RVL Pharmaceuticals PLC are of similar size ($14.1M and $13.7M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −184.9%) and the lower return on invested capital (−367.5% vs −80.5%). Across the 14 metrics below, Pasithea Therapeutics Corp. leads on 9 and RVL Pharmaceuticals PLC on 5.

Valuation

Metric KTTA RVLP Biotechnology median
P/E n/m n/m 8.50
P/S 27.71 n/m 9.71
P/B 0.27 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.39 n/m 0.64
EV/Sales (66.34) 1.05 9.21
Earnings yield (376.19%) 0.00% (33.15%)
Free cash flow yield (130.85%) 0.00% (25.50%)

Profitability

Metric KTTA RVLP Biotechnology median
Gross margin 0.00% 74.73% 65.16%
Operating margin 0.00% (191.72%) 0.00%
Net margin 0.00% (184.91%) 0.00%
Free cash flow margin 0.00% (128.42%) 0.00%
Return on equity (65.49%) (182.44%) (56.36%)
Return on assets (61.97%) (64.94%) (48.04%)
Return on invested capital (367.46%) (80.54%) 0.00%

Growth

Metric KTTA RVLP Biotechnology median
Revenue growth (TTM) — 5.64% 6.02%
EPS growth (last fiscal year) 77.07% 39.58% 30.26%
Revenue growth, 5-year CAGR — (27.35%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KTTA RVLP Biotechnology median
Debt to equity 0.00 3.54 0.00
Current ratio 26.25 0.38 4.72
Net debt to EBITDA 2.74 (0.29) 0.96

Dividend

Metric KTTA RVLP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KTTA RVLP Biotechnology median
Market cap 13.70m 14.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack